相似文献
1
MDSCs: friend or foe in systemic lupus erythematosus.
Cell Mol Immunol. 2019 Dec;16(12):937-939. doi: 10.1038/s41423-019-0271-8. Epub 2019 Aug 20.
2
Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus.
Arthritis Rheumatol. 2016 Nov;68(11):2717-2727. doi: 10.1002/art.39767.
3
Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
Front Immunol. 2021 Apr 27;12:606024. doi: 10.3389/fimmu.2021.606024. eCollection 2021.
4
Dual roles of myeloid-derived suppressor cells in various diseases: a review.
Arch Pharm Res. 2024 Jul;47(7):597-616. doi: 10.1007/s12272-024-01504-2. Epub 2024 Jul 15.
5
Role of suppressor T cells in lymphopoietic disorders.
Clin Haematol. 1977 Jun;6(2):439-78.
6
Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs.
Clin Sci (Lond). 2016 Aug 1;130(16):1453-67. doi: 10.1042/CS20160311. Epub 2016 May 26.
7
Increased CD14HLA-DR Myeloid-Derived Suppressor Cells Correlate With Disease Severity in Systemic Lupus Erythematosus Patients in an iNOS-Dependent Manner.
Front Immunol. 2019 May 29;10:1202. doi: 10.3389/fimmu.2019.01202. eCollection 2019.
8
Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2/HO-1 pathway.
Free Radic Biol Med. 2019 Nov 1;143:260-274. doi: 10.1016/j.freeradbiomed.2019.08.013. Epub 2019 Aug 13.
9
Immune response potential and its genetic regulation in autoimmune diseases. Alterations in systemic lupus erythematosus and thyroid autoimmune diseases.
Ann N Y Acad Sci. 1986;475:227-30. doi: 10.1111/j.1749-6632.1986.tb20871.x.
10
Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation.
Arthritis Rheumatol. 2016 Feb;68(2):449-61. doi: 10.1002/art.39441.
引用本文的文献
1
Immune cells in systemic lupus erythematosus: biology and traditional Chinese medicine therapy.
Acta Pharmacol Sin. 2025 Apr 17. doi: 10.1038/s41401-025-01554-2.
2
Dual roles of myeloid-derived suppressor cells in various diseases: a review.
Arch Pharm Res. 2024 Jul;47(7):597-616. doi: 10.1007/s12272-024-01504-2. Epub 2024 Jul 15.
3
Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma.
Mol Cancer. 2024 Feb 29;23(1):45. doi: 10.1186/s12943-024-01936-w.
4
Th17/Treg balance is regulated by myeloid-derived suppressor cells in experimental autoimmune myocarditis.
Immun Inflamm Dis. 2023 Jun;11(6):e872. doi: 10.1002/iid3.872.
5
Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and suppresses autoimmunity.
Signal Transduct Target Ther. 2023 Jan 23;8(1):28. doi: 10.1038/s41392-022-01208-3.
6
New Aspects of Kidney Fibrosis-From Mechanisms of Injury to Modulation of Disease.
Front Med (Lausanne). 2022 Jan 12;8:814497. doi: 10.3389/fmed.2021.814497. eCollection 2021.
7
Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages.
Cancer Res. 2021 Dec 1;81(23):5977-5990. doi: 10.1158/0008-5472.CAN-21-1148. Epub 2021 Oct 12.
8
C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1 M-MDSCs in relieving lupus-like symptoms.
Cell Death Dis. 2021 Sep 3;12(9):829. doi: 10.1038/s41419-021-04052-5.
9
Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases.
Cell Immunol. 2021 Apr;362:104300. doi: 10.1016/j.cellimm.2021.104300. Epub 2021 Feb 4.
10
Neutrophils-Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
Front Immunol. 2019 Nov 22;10:2734. doi: 10.3389/fimmu.2019.02734. eCollection 2019.
Zotero 插件